UBS Group
IH

UBS Group’s iHuman IH Stock Holding History

UBS Group’s Portfolio IH Stock Details IH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$181 Buy
129
+30
+30% +$48 ﹤0.01% 10022
2026
Q1 		$169 Sell
99
-90
-48% -$167 ﹤0.01% 10057
2025
Q4 		$397 Buy
189
+187
+9,350% +$495 ﹤0.01% 9986
2025
Q3 		$6 Sell
2
-4,868
-100% -$13.5K ﹤0.01% 10222
2025
Q2 		$12.2K Buy
4,870
+3,766
+341% +$8.39K ﹤0.01% 8748
2025
Q1 		$2.34K Sell
1,104
-2,210
-67% -$4.41K ﹤0.01% 9357
2024
Q4 		$5.6K Sell
3,314
-1,212
-27% -$2.17K ﹤0.01% 8631
2024
Q3 		$10.4K Buy
+4,526
New +$7.41K ﹤0.01% 7726
2023
Q4 		– Sell
-181
Closed -$547 – 9577
2023
Q3 		$547 Buy
+181
New +$560 ﹤0.01% 8413
2023
Q2 		– Sell
-53
Closed -$172 – 9226
2023
Q1 		$172 Sell
53
-1,912
-97% -$6.16K ﹤0.01% 9160
2022
Q4 		$5.11K Sell
1,965
-1,692
-46% -$3.44K ﹤0.01% 9221
2022
Q3 		$8K Buy
3,657
+710
+24% +$1.55K ﹤0.01% 8719
2022
Q2 		$7K Buy
+2,947
New +$7.76K ﹤0.01% 8493
2022
Q1 		– Sell
-3,990
Closed -$11K – 10534
2021
Q4 		$11K Buy
3,990
+3,169
+386% +$13.6K ﹤0.01% 8670
2021
Q3 		$4K Buy
+821
New +$6.11K ﹤0.01% 8645
2021
Q2 		– Sell
-549
Closed -$7K – 9568
2021
Q1 		$7K Buy
+549
New +$9.69K ﹤0.01% 8152

Other funds holding IH

Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Credit Agricole
Credit Agricole Montrouge Cedex, France $49.3B AUM 36.45% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return

UBS Group's IH Position: Q2 2026 in Review

UBS Group increased its iHuman (IH) stake by 30% in Q2 2026, buying an estimated $48 and bringing the position to 129 shares worth $181. The position accounts for ﹤0.01% of the portfolio, ranked #10022.

UBS Group first reported a position in IH in Q1 2021 and has held it in 16 quarters since. The position peaked at $12.2K in Q2 2025. 8 funds tracked by Wall St. Rank hold IH as of Q2 2026.

  • UBS Group held 129 shares of iHuman worth $181 as of Q2 2026.
  • UBS Group bought 30 iHuman shares in Q2 2026, an estimated $48.
  • iHuman made up ﹤0.01% of UBS Group's portfolio in Q2 2026, its #10022 holding.
  • UBS Group first reported a position in iHuman in Q1 2021 and has held it in 16 quarters since.
  • UBS Group's iHuman position peaked at $12.2K in Q2 2025.
  • 8 funds tracked by Wall St. Rank held iHuman as of Q2 2026.

Based on UBS Group's 13F filing for Q2 2026, filed 13 Aug 2026.